Oral Bleeding in Multiple Myeloma: An Uncommon but Recognized Manifestation
Bleeding from the mouth is NOT a normal or typical manifestation of multiple myeloma, but it can occur as a rare complication due to several underlying mechanisms including coagulation abnormalities, platelet dysfunction, and gingival involvement from plasma cell infiltration.
Understanding the Bleeding Mechanisms
While the major EHA-ESMO and EHA-EMN guidelines 1, 2 focus primarily on standard MM complications (anemia, bone disease, infections, renal impairment), they notably do not list oral bleeding as a common presenting feature. This absence from guideline discussions underscores that oral bleeding is not a typical manifestation.
However, when oral bleeding does occur in MM, several mechanisms may be responsible:
Coagulation Abnormalities
- Acquired dysfibrinogenemia can cause severe bleeding, including life-threatening hemorrhagic complications 3
- Paraprotein-induced platelet dysfunction and shortened platelet survival 3
- Thrombin-inhibiting substances produced by the myeloma clone 4
- These coagulation defects, while uncommon, can manifest as spontaneous gingival bleeding 5
Direct Oral Involvement
- Gingival infiltration by plasma cells can cause gingival enlargement with bleeding tendency 5
- Osteolytic jaw lesions (occurring in ~90% of patients with oral manifestations) can lead to bleeding during dental procedures 6, 7
- The mandible is affected more frequently than the maxilla, particularly in the ramus, angle, and molar regions 5
Clinical Context and Red Flags
If oral bleeding is present, consider these scenarios:
- Spontaneous gingival bleeding without trauma suggests coagulation abnormalities requiring immediate hematologic evaluation 3, 4
- Post-dental procedure bleeding that is excessive or difficult to control may indicate undiagnosed MM with jaw involvement 7
- Associated findings that increase suspicion:
Management Approach
For active oral bleeding in MM patients:
- Immediate assessment of coagulation profile (PT, aPTT, fibrinogen, thrombin time)
- Consider acquired dysfibrinogenemia if standard tests are abnormal - treat with dexamethasone and antifibrinolytic agents (tranexamic acid) 3
- Evaluate for direct plasma cell infiltration of gingiva or jaw with imaging and biopsy if indicated
- Initiate MM-directed therapy promptly, as treatment of the underlying disease resolves coagulation abnormalities 4
Critical Pitfalls to Avoid
- Do not dismiss oral bleeding as "normal" for MM - it requires investigation for the underlying cause
- Review panoramic radiographs carefully before any dental procedures in MM patients to identify osteolytic lesions that increase bleeding risk 7
- Do not attribute all bleeding to thrombocytopenia alone - MM can cause qualitative platelet defects and coagulation factor abnormalities even with normal platelet counts 3
The key distinction: While anemia is an expected complication mentioned in guidelines 1, oral bleeding represents an unusual presentation requiring specific diagnostic evaluation and targeted management beyond standard MM supportive care.